Navigation Links
Nobel Prize Awarded to Foundation for Biomedical Research Board Member
Date:10/10/2007

WASHINGTON, Oct. 10 /PRNewswire-USNewswire/ -- The Foundation for Biomedical Research (FBR) congratulates Mario R. Capecchi today for the richly deserved honor of the 2007 Nobel Prize in Physiology or Medicine. Capecchi, who sits on FBR's Board of Governors, is currently a Distinguished Professor and Co-Chair of the Human Genetics Department at the University of Utah, School of Medicine.

"Groundbreaking research such as Dr. Capecchi's has enabled the study of diseases in a way never before thought possible," said FBR President Frankie L. Trull. "This further demonstrates the incredible power and promise of the humane use of animal models in medical research."

The Nobel Foundation recognized Capecchi and two other researchers for the discovery of "principles for introducing specific gene modifications in mice by the use of embryonic stem cells." Their studies resulted in genetically altered mouse models, innovating the way researchers work to combat such diseases as cancer, diabetes and Alzheimer's.

Capecchi's Nobel Prize-winning work involved gene targeting in mouse embryonic stem cells, allowing scientists to study the pathology of disease in a living system whose genes have been either inactivated or modified. Scientists can now target specific disease-causing genes in an effort to discover new cures or treatments that afflict both humans and animals.

Upon joining FBR's Board of Governors, Capecchi said, "I am a very strong advocate for the respect and support of animal research. My scientific life has been devoted to the use of mouse models for the understanding of the development of therapies of human disease as well as for the pathologies."

FBR's Board of Governors now includes ten Nobel Laureates. Capecchi is a recipient of numerous other awards, including the Albert Lasker Award in 2001.

FBR is the nation's foremost organization devoted to promoting public understanding, respect, and support for the humane and responsible use of animals in medical and scientific research. For more information on FBR, please visit its Web site at http://www.fbresearch.org.


'/>"/>
SOURCE Foundation for Biomedical Research
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Vastox Awarded £400,000 Grant to Support R&D at Carbohydrate Chemistry Facility
2. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
3. Lupus Foundation of America Statement on Results for Clinical Study of CellCept Released by Aspreva Pharmaceutical Company
4. The Christopher and Dana Reeve Foundation Expresses Disappointment Over President Bushs Veto of the Stem Cell Research Enhancement Act
5. Hypertension Education Foundation Survey Results Announced At American Society For Hypertension Annual Meeting Suggests Improved Control Of High Blood Pressure, But Misconceptions Still Exist
6. The International Myeloma Foundation Reports Positive Shift In Treatment Paradigm For Patients
7. Research Supported by Samuel Waxman Cancer Research Foundation Discovers Mode of Action of Arsenic-Based Drugs in Destroying Cancer Cells
8. The International Myeloma Foundation Says New Clinical Trial Results Could Improve Survival While Reducing Side Effects For Many Patients
9. The American Liver Foundation Urges Cautious Optimism about CDC Report on Declining Acute Hepatitis Infection Rates
10. Advanced Magnetics Announces Presentation of Ferumoxytol Data at the National Kidney Foundation 2007 Spring Clinical Meetings
11. Vical Interim Clinical Results Demonstrate Safety and Tolerability of Inovio Biomedicals Electroporation DNA Delivery Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... , Dec. 9, 2016 Department of ... temporary regulations for medical marijuana dispensaries under Act 16 ... Bulletin , and are now available online . ... needed in the plan for operation; process for dispensing ... as well as where the dispensary facilities can be ...
(Date:12/9/2016)... 9, 2016  Forge Therapeutics, Inc. today announced ... Exchange: EVT, TecDAX, ISIN: DE0005664809) to advance its ... treatment of bacterial infections including those caused by ... an attractive antibacterial target for more than the ... chemical starting points has hampered its progress. Forge ...
(Date:12/8/2016)... 8, 2016 Australia Ophthalmic Lasers Market Outlook ... Ophthalmic Lasers Market Outlook to 2022", provides key market ... provides value, in millions of US dollars, volume (in ... Excimer Lasers, Femtosecond Lasers and YAG Lasers. The ... for each of these market segements, and global corporate-level ...
Breaking Medicine Technology:
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... The ... Drug Dependence, Inc. (NCADD) is recommending the film Whispering Spirits and ... the District of Columbia as an education tool in the war against teen drug ...
(Date:12/9/2016)... ... 2016 , ... Mediaplanet today announces distribution of the latest edition of “Transplants,” ... up as an organ donor for the 123,000 people in the United States who ... save up to 8 saves through organ donation and enhance many others through tissue ...
(Date:12/9/2016)... ... ... "I had a terrible time trying to get my grandson to use ... nebulizer had a more child-friendly design, then children would be more likely to look ... to avoid the need to deliver medication via a nebulizer mask. The design will ...
(Date:12/8/2016)... Tampa, FL (PRWEB) , ... December 08, 2016 ... ... been awarded accreditation with distinction by the Undersea and Hyperbaric Medical Society (UHMS), ... patients with advanced care and patient safety. Only a few hospitals and facilities ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... pleased to announce that “Natural Language Processing–Enabled and Conventional Data Capture Methods for ... JMIR Medical Informatics . , Results of the comparative usability study demonstrate ...
Breaking Medicine News(10 mins):